17.01.2013 - In the controversy over the harmlessness of GM maize, the EU food watchdog EFSA has published all data from its safety assessment of Monsanto’s NK603.
The EFSA’s move was triggered by „the level of public interest“ after Caen-based researcher Gilles-Eric Séralini claimed Monsanto’s GM maize NK603 harmed the health of lab rats in an experimental setting last September. However, researchers all over the world challenged Seralini’s findings saying his data were insufficient and would require publication of the raw data.
Up to now, the scientific head of the GMO-sceptic organisation Criigen refused to do so. But in a press conference at the European Parliament Séralini announced he will publish his data now as the EFSA opened up its data first. The EFSA, which reviews the use and authorisation of GM crops and foodstuffs, in November rejected a report by Seralini which linked NK603 to cancer found in laboratory rats as failing to meet “acceptable scientific standards.“ The EFSA decision is part of a major initiative designed to facilitate access to data, enhancing transparency in risk assessment. “Risk assessment is an evolving science and EFSA is always willing to review its past work should new robust science bring a new perspective to any of the Authority’s previous findings, „ said EFSA chief Catherine Geslain-Lanéelle.
12.05.2015 US pharma is coming to European biotech to fill their pipeline. Pfizer is paying €77.5m for an option on Dutch AM-Pharma, while Juno Therapeutics acquired German biotech Stage Cell Therapeutics for around €72m.
20.05.2015 The Scottish Government has announced it will double the amount of funds for rare diseases. The New Medicines Fund that was created last year for this purpose will be increased to £80m (€112m).
30.04.2015 The European Parliament has given the go-ahead on a new law limiting the use of harmful crop-based biofuel in the transport sector. The decision marks a breakthrough in the EU’s approach to biofuels.